Page last updated: 2024-08-24

oseltamivir and Hemorrhage

oseltamivir has been researched along with Hemorrhage in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (12.50)	29.6817
2010's	5 (62.50)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Brown, JN; Bryan, WE; Randolph, AE; Smith, KR; Townsend, ML; Vanderman, AJ; Woodard, CL	1
Han, P; Hou, M; Hou, Y; Li, D; Liu, X; Peng, J; Qiu, J; Shao, L; Sun, L; Wang, J; Wang, Z; Xu, M; Yu, Y; Yuan, C; Zhao, H; Zhou, H	1
Kelman, JA; MaCurdy, TE; Mosholder, AD; Racoosin, JA; Shoaibi, A; Wernecke, M; Worrall, C; Young, S	1
Chau, NQ; Farrar, J; Hien, ND; Hien, NT; Hien, TT; Horby, P; Khang, DD; Liem, NT; Long, HT; Mai, le Q; Taylor, WR; Tung, CV; Wertheim, H	1
Kobayashi, N; Koizumi, T; Kubo, K; Tsushima, K; Urushihata, K; Ushiki, A; Yokoyama, T	1
Hurst, BL; Smee, DF; Wong, MH	1
Ahn, JH; Choi, HJ; Kwak, IS; Lee, SB; Lee, YJ; Rhee, H; Seong, EY; Song, SH	1
Cho, SH; Hong, KS; Jung, JW; Kang, HR; Kwon, JW; Lee, SH; Yu, KS	1

Trials

1 trial(s) available for oseltamivir and Hemorrhage

Article	Year
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial. The Lancet. Haematology, 2021, Volume: 8, Issue:4 Topics: Administration, Oral; Adult; China; Dexamethasone; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Glucocorticoids; Hemorrhage; Humans; Intention to Treat Analysis; Male; Middle Aged; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Safety; Treatment Outcome	2021

Article

Year

Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.

The Lancet. Haematology, 2021, Volume: 8, Issue:4

Topics: Administration, Oral; Adult; China; Dexamethasone; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Glucocorticoids; Hemorrhage; Humans; Intention to Treat Analysis; Male; Middle Aged; Oseltamivir; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Safety; Treatment Outcome

2021

Other Studies

7 other study(ies) available for oseltamivir and Hemorrhage

Article	Year
Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy. Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Blood Coagulation; Drug Interactions; Drug Monitoring; Female; Hemorrhage; Humans; International Normalized Ratio; Kidney; Male; Middle Aged; Oseltamivir; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Venous Thromboembolism; Warfarin	2020
Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries. The Annals of pharmacotherapy, 2013, Volume: 47, Issue:11 Topics: Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Cohort Studies; Drug Interactions; Female; Hemorrhage; Humans; Influenza, Human; International Classification of Diseases; Logistic Models; Male; Medicare; Middle Aged; Multivariate Analysis; Oseltamivir; Pandemics; Retrospective Studies; United States; Warfarin	2013
Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jun-15, Volume: 48, Issue:12 Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Diarrhea; Female; Hemorrhage; Humans; Infant; Influenza A Virus, H5N1 Subtype; Influenza, Human; Lung; Lymphopenia; Male; Middle Aged; Oseltamivir; Radiography; Retrospective Studies; Risk Factors; Transaminases; Treatment Outcome; Vietnam; Young Adult	2009
Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:5 Topics: Acute Lung Injury; Adult; Antiviral Agents; Female; Glycine; Hemorrhage; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung Diseases; Oseltamivir; Sulfonamides; Treatment Outcome	2010
Effects of TheraMax on influenza virus infections in cell culture and in mice. Antiviral chemistry & chemotherapy, 2011, Jul-04, Volume: 21, Issue:6 Topics: Administration, Intranasal; Animals; Antiviral Agents; Camellia sinensis; Cell Line; Dogs; Drug Evaluation, Preclinical; Hemorrhage; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Lung; Lung Diseases; Mice; Mice, Inbred BALB C; Nasal Cavity; Orthomyxoviridae Infections; Oseltamivir; Plant Extracts; Sambucus; Toxicity Tests; Weight Loss	2011
Pandemic H1N1 influenza A viral infection complicated by atypical hemolytic uremic syndrome and diffuse alveolar hemorrhage. Clinical and experimental nephrology, 2011, Volume: 15, Issue:6 Topics: Adult; Antiviral Agents; Atypical Hemolytic Uremic Syndrome; Hemodiafiltration; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung Diseases; Male; Oseltamivir; Pandemics; Plasma Exchange; Pulse Therapy, Drug; Republic of Korea; Steroids; Tomography, X-Ray Computed; Treatment Outcome	2011
Effect of oseltamivir on bleeding risk associated with warfarin therapy: a retrospective review. Clinical drug investigation, 2012, Feb-01, Volume: 32, Issue:2 Topics: Administration, Oral; Adult; Aged; Anticoagulants; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Hemorrhage; Hospitals, University; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; International Normalized Ratio; Male; Middle Aged; Oseltamivir; Prothrombin Time; Retrospective Studies; Time Factors; Warfarin	2012